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Nude Mice
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Maryland 21205
The fungal metabolite cyclosporin A (CsA)' is a potent immunosuppressant
that has specific effects on T cells and can induce permanent acceptance ofallo-
grafts in certain species (reviewed in reference 1). However, CsA is not only able
to induce tolerance to non-self, but also to break tolerance to self. We recently
demonstrated that CsA caused organ-specific autoimmune disease in mice when
the drug was administered to newborns even for a limited period (Sakaguchi, S.,
and N. Sakaguchi, submitted for publication) .
It was previously shown that various organ-specific autoimmune diseases
could be produced in mice by depleting Lyt+ T cells, including L3T4+ (CD-4+)
T cells as well as Lyt-2+ (CD-8+) T cells, leaving Thy-1+, Lyt- T cells in the
immune system (2). CsA is known to affect thymopoiesis (3, 4) . We recently
showed that CsA selectively abrogated L3T4+ T cells and Lyt-2+ T cells in the
murine thymus (Sakaguchi, S., and N. Sakaguchi, submitted for publication).
The issues then addressed are: (a) whether CsA causes autoimmune disease by
primarily affecting the thymus and interfering with the thymic production of
certain T cells that are keeping the expansion of self-reactive T cells in check;
and (b) why administration of CsA to newborns can cause autoimmune disease,
but CsA treatment of adult mice can not. We showed in this report that engraft-
ing of the thymus from CsA-treated euthymic (nu/+) mice, either newborns or
adults, into syngeneic, athymic nude (nu/nu) mice produced various organ-spe-
cific autoimmune diseases.
Materials and Methods
Mice.
￿
BALB/c nu/-{- and nu/nu mice (6 wk old) were purchased from Life Science
Associates, St. Petersburg, FL. To obtain newborn mice, nu/+ mice were mated in our
animal facility.
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'Abbreviations used in this paper: CsA, cyclosporin A; IF, immunofluorescence; 00, olive oil; PC, pari-
etal cells.
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CsA Treatment.
￿
CsA, a gift from Sandoz, Co. Ltd., Basel, Switzerland, was dissolved
in olive oil (00) (Sigma Chemical Co., St. Louis, MO) at a concentration of 5 mg/ml,
then further diluted to the appropriate concentrations for intraperitoneal injection at a
volume of 50 tel for newborn mice or 100 ul for adult mice.
Transplantation of Thymus into nu/nu Mice.
￿
Mice were anesthesized by Nenbutal and
the kidney was exposed by retroperitoneal incision; two thymic lobes from neonatally
CsA- or 00-treated mice, or one lobe, cut into three to five pieces, from adult CsA- or
00-treated mice were engrafted under the renal capsule of bilateral kidneys with fine
forceps.
ELISA for Detection of Autoantibodies.
￿
For detecting autoantibodies against the gastric
parietal cells (PC), the microsome/plasma membrane fraction of gastric mucosa was pre-
pared according to the method of Mariotti et al. (5) . Details of the method were
described elsewhere (Sakaguchi, S., and N. Sakaguchi, submitted for publication). Briefly,
the fundal portion of BALB/c mice stomachs was homogenized with an Ultraturax TP/
18 homogenizer with 4 vol of 0 .25 M sucrose, centrifuged at 9,000 g for 30 min; the
supernatant was centrifuged again at 105,000 g for 60 min. The pellet was washed with
PBS and solublized with 1 .0% Triton X-100 in 0.01 M PBS. The solution was diluted
1 :1,000 with PBS (final protein concentration 25 Feg/ml) and used for overnight coating
of 96-well ELISA plates (Flow Laboratories, Inc., McLean, VA). For detection of anti-
thyroglobulin antibodies, ELISA plates were coated overnight with purified mouse thy-
roglobulins (2 kg/ml). ELISA were performed according to the method of Voller et al .
(6). Briefly, the plates were incubated for 1 h at room temperature with the diluted test
sera (twofold serial dilutions starting from 1 :10 dilution) ; after washing, they were incu-
bated for 1 h with 1 Ag/ml of alkaline phosphatase-conjugated anti-mouse IgG (Sigma
Chemical Co.); and the absorbance at 405 nm was measured by an ELISA reader
(MR580; Dynatech Laboratories, Inc., Alexandria, VA) after 30-min color development
with 1 mg/ml of p-nitrophenyl disodium hexahydrate (Sigma Chemical Co.) in 10%
diethanolamine buffer, pH 9.8. In this anti-PC autoantibody assay, the absorbance
with the 1 :10 diluted sera from 3-4-mo-old normal BALB/c mice was 0.07 ± 0.028 (n
= 50). The titer of anti-PC autoantibody was, therefore, defined as the highest dilution
at which the absorbance was >0.1 . There was a good correlation between the titer and
specificity of anti-PC antibodies assessed by indirect immunofluorescence (IF) tests with
tissue sections and those by ELISA (Sakaguchi, N., and S. Sakaguchi, manuscript in
preparation) .
Other Methods.
￿
Tissue-specific autoantibodies were surveyed by indirect IF test with
cryostat sections of normal mouse tissues, as previously described (2) . Histology was pre-
pared by paraffin embedding and stained with hematoxylin and eosin.
Results and Discussion
Development of Autoimmune Disease in nu/nu Mice after Engrafting Thymus from
CsA-Treated nu/-f- Mice. 6-wk-old female nu/nu mice were engrafted with
either one thymus from 7-d-old female nu/-f mice treated daily with CsA (10
mg/kg body weight per day) for 1 wk from the day of birth, or one thymic lobe
from the adult female nu/+ mice administered daily with CsA (20 mg/kg per
day) for 2 wk. When examined histologically 3 mo later, some of the recipient
nu/nu mice developed organ-specific autoimmune diseases, such as gastritis,
oophoritis, thyroiditis, or insulitis whether CsA-treated donor mice were new-
born or adult (Table 1). Each autoimmune disease was accompanied by circulat-
ing autoantibodies specific for gastric parietal cells, oocytes (zona pellucida and/
or ooplasm), thyroglobulin, or cell surface of Langerhans' islet cells, respec-
tively. Histological and serological characteristics of each autoimmune disease
were similar to those produced in euthymic mice by neonatal CsA-treatment
(Sakaguchi, S ., and N. Sakaguchi, submitted for publication) or those induced
in nu/nu mice by the transfer of T cell subsets from nu/ -l- mice (2) (see refer-TABLE I
Induction ofAutoimmune Disease in nu/nu Mice by Engrafting the Thymusfrom CsA-treated
nu/+ Mice
* Incidenceof autoimmune disease was assessed histologically. See reference 2 for histopathology of
each autoimmune disease. See Fig. 1 for the titers of autoantibodies.
"BALB/c nu/+ mice, newborn or adult (6 wk old), were inoculated dailywith CsA (10 or 20 mg/kg
body weight per day, respectively) or 00 from thedayof birth (day 0) to day 6or for2 wk in adults.
Thymus was removed the day after the last inoculation of CsA and transplanted under the kidney
capsule of 6-wk-old female nu/nu mice. The recipient nu/nu mice were killed 3 mo later forexam-
ination of histologyand check of autoantibodies.
ence 2 for histology and autoantibodies demonstrable by indirect IF; a manu-
script is in preparation for pathology of insulitis and anti-islet cell autoantibod-
ies). Three nu/nu mice also developed mild systemic vasculitis (data not shown).
All nu/nu mice transplanted with the thymus showed elevated level of y-globu-
lins (two to four times higher than the nontransplanted nu/nu mice). However,
significant difference was not found between the groups transplanted with CsA-
treated or 00-treated thymus in terms of serum IgG level, the autoantibody
titer against single-stranded DNA, or spontaneous development of antibodies
against non-self antigens, such as trinitrophenyl haptens (data not shown). Fig.
1 shows the titer and time course of the development of autoantibodies specific
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FIGURE 1 . BALB/c female
athymic nu/nu mice (6 wk old)
were engrafted with the thy-
mus from the 7-d-old mice
treated with CsA from day 0
to 6 (A and C, or for 2 wk in
adult mice (B and D). Anti-PC
autoantibodies were assayed
o by ELISA (A and B). Anti-
° oocyte autoantibodies were
macroscopically and histologi-
cally evident (see reference 2
for details of pathological cri-
teria); (0) intact gastric mu-
cosa or ovaries; (0), control
nu/nu mice engraftedwith the
thymus from 00-treated 7-d-
old mice (A and C), or from
adult nu/+ mice treated with
00 for 2 wk (B and D). His-
tologically, no pathological
changes were observed in
these groups of mice.
Group Treatmentof thymus
donornu/+ mice i
Incidence
Gastritis
of autoimmune
Oophoritis
disease in nu/nu
Thyroiditis
mice*
Insulitis
A CsA from day 0 to 6 5/6 2/6 0/6 1/6
B 00 from day 0 to 6 0/6 0/6 0/6 0/6
C CsA for 2 wk in adult 4/7 4/7 1/7 0/7
D 00 for 2 wk in adult 0/6 0/6 0/6 0/61482
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TABLE II
Prevention ofAutoimmune Disease in nu/nu Mice by Inoculation of Thymocytesfrom Normal
nu/+ Mice
* See Table I.
:Thymus obtained from 8-wk-old nu/+ mice treated with CsA (20 mg/kgbody weight per day) for
2 wk was transplanted.
¢Thymocyte suspensions (10") were intravenouslyinoculated at the time of thymus transplantation.
a Thymocyte suspensions (10") were prepared from 8-wk-old nu/+ mice CsA treated for 2 wk.
for gastric parietal cells or oocytes in the thymus-engrafted nu/nu mice. Control
nu/nu mice transplanted with the thymuses from 00-treated mice did not show
histological evidence for autoimmune disease, but some mice developed a low
titer of anti-PC autoantibodies (Fig. 1). The mice with histologically evident gas-
tritis or oophoritis generally showed high titer of anti-PC or anti-oocyte auto-
antibodies, respectively. Some of the recipients of CsA-treated thymus, however,
developed high titer of anti-PC autoantibodies of IgG isotype, but little histo-
logical lesions. It is likely in these mice that helper T cells for autoantibody pro-
duction were active, but the activity of effector T cells of cell-mediated immunity
might be insufficient to elicit tissue damage, since our previous study (7) on
similar organ-specific autoimmune disease induced by early neonatal thymec-
tomy showed the definitive role of cell-mediated immune reactions in destruc-
tion of the target organs.
Inoculation of spleen cell suspensions from CsA-treated adult mice did not
produce any histological or serological autoimmunity. Transfer of thymocyte cell
suspensions from the CsA-treated adult mice, however, induced anti-PC auto-
antibodies (positive at dilution of 320-640 by ELISA), although histological
lesions were not evident.
At the time of sacrifice, the transplanted thymuses were histologically popu-
lated with massive lymphocytes. The composition of thymocyte subsets was sim-
ilar to that of a normal adult thymus. No significant difference was found in the
number of peripheral Thy-1+ cells and the composition of T cell subsets
between nu/nu mice transplanted with CsA or 00-treated thymus, i.e., Thy-1+
cells, L3T4 + cells, and Lyt-2+ cells in the lymph nodes were, ^-50, ^-40, and
-10%, respectively.
Prevention of Autoimmune Disease by Inoculation of Thymocytes.
￿
When thymo-
cytes were inoculated immediately after transplantation of CsA-treated thymus,
thymocyte suspensions (108) from normal nu/-I- mice could suppress the devel-
Group Treatment of nu/nu mice
Incidence
Gastritis
of autoimmune
nu/nu mice*
Oophoritis
diseases in
Thyroiditis
A Transplantation of CsA-treated nu/+ thymus: 5/6 3/6 0/6
B Transplantation of CsA-treated nu/+ thymus 1/6 0/6 0/6
plus inoculation of normal nu/+
thymocytes$
C Transplantation of CsA-treated nu/+ thymus 4/5 2/5 1/5
plus inoculation of thymocytes from CsA-
treated nu/+ micellTABLE III
Prevention ofAutoimmune Disease in nu/nu Mice by Transplanting the Thymusfrom Normal
nu/+ Mice
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* See legend to Table I.
IThymus from the CsA-treated adult nu/+ mice (8 wk old) wastransplanted in the rightkidney, and
thethymus from normal adult nu/-I- mice (8-10 wk old) was transplanted in theleft kidney.
§ Thymus from the CsA-treated adult nu/-t- mice was transplanted in the right kidney, and normal
nu/-1- thymus was transplanted in the left kidney 2 wk later.
opment of autoimmune disease, while those from CsA-treated nu/ + mice could
not (Table II). When the composition of thymocyte subsets was examined by
two-color cytofluorometric analysis, L3T4+ , Lyt-2 - and L3T4- ,Lyt-2+ thymo-
cytes were found to be absent from the thymus of CsA-treated mice (Sakaguchi,
S., and N. Sakaguchi, submitted for publication). Thus, it is highly likely that
CsA caused autoimmune disease by interfering selectively with the thymic pro-
duction of certain suppressor T cells controlling self-reactive T cells.
Prevention of Autoimmune Disease by Transplanting Normal Thymus with CsA-
Treated Thymus. Cotransplantation of the thymus from the normal adult nu/ +
mice with the thymus from CsA-treated mice prevented autoimmune disease;
however, transplantation of normal thymus 2 wk after engrafting CsA-treated
thymus could not (Table III) . We suggested earlier (8) that suppressor T cells
are regulating the early stage of proliferation/differentiation of effector T cells,
but they can not suppress the T cells engaging in ongoing effector functions. It
is plausible that a number of effector precursors generated through the CsA-
treated thymus in an unchecked manner might have differentiated by 2 wk into
active effector T cells, which the suppressor T cells in the normal thymus trans-
planted 2 wk later were unable to control . Furthermore, the result suggests that
depletion of suppressor T cells in the thymus does not need to be permanent to
induce autoimmune disease. When suppressor T cells eventually recover in the
CsA-treated thymus, they seem to be incapable of controlling the self-reactive T
cells that have proliferated/differentiated by then into effector T cells of
autoimmune disease.
Prevention of Autoimmune Disease by Inoculation of Spleen Cellsfrom Adult nu/+
Mice, but Notfrom nu/+ Newborns. Inoculation of spleen cell suspensions (4 X
107 nucleated cells with 25-30% of Thy-1 + cells) prepared from normal, 10-12-
wk-old nu/+ mice immediately after engrafting the thymus from CsA-treated
nu/+ mice completely inhibited the occurrence of autoimmune disease (Table
IV) . In contrast, transfer of spleen cell suspensions (4 X 107 nucleated cells with
<5% of Thy-1 + cells) prepared from 1-3-d-old nu/+ or +/+ newborn mice
Group Treatmentof nu/nu mice
Incidence
Gastritis
of autoimmune
nu/nu mice*
Oophoritis
disease in
Thyroiditis
A Transplantation of CsA-treated nu/+ thymus 0/6 0/6 0/6
plus normal nu/-I- thymusl
B Transplantation of CsA-treated nu/-f thymus 3/6 2/6 0/6
and transplantation of normal nu/-I-
thymus 2 wk later§1484
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TABLE IV
Prevention of Autoimmune Disease in nu/nu Mice by Inoculation ofSpleen Cell Suspensions
from nub+ Mice
* See Table I.
" Thymus obtained from 8-wk-old nu/-f- mice treated with CsA (20 mg/kgbody weight per day) for
2 wk was transplanted.
4 Spleen cell suspensions (4 X 107) from 10-12-wk-old nu/+ mice were intravenously inoculated
immediately after transplanting the thymus from the CsA-treated adult nu/-I- mice.
II Spleen cell suspension (4 X 107) from 1-3-d-old nu/+ mice were inoculated immediately after
transplanting the thymus from CsA-treated adult nu/-/- mice.
could not prevent the disease. In the previous study, we demonstrated that CsA
could deplete thymocytes irrespective of the age of mice. However, administra-
tion of CsA to euthymic mice caused organ-specific autoimmune diseases only
when the drug was administered to newborns; CsA treatment of adult mice
failed to induce autoimmune disease even with higher doses of CsA and longer
treatment periods (Sakaguchi, S., and N. Sakaguchi, submitted for publication) .
These results taken together suggest the following: (a) normal thymus is contin-
uously producing potential self-reactive (autoimmune) clones of T cells as well
as suppressor T cells, the latter dominantly controlling the former; (b) CsA can
selectively abrogate the thymic production of such suppressor T cells in mice at
any age, allowing unchecked production of self-reactive T cells through the thy-
mus; and (c) however, for self-reactive T cells to proliferate/differentiate into
effector T cells of autoimmune disease, active suppressor T cells must be absent
in the periphery or have not yet migrated to the periphery. Thus, engrafting of
the thymus from CsA-treated mice into T cell-deficient nu/nu mice or CsA
administration to euthymic newborn mice can cause autoimmune disease, but
CsA administration to euthymic adult mice can not.
Summary
Organ-specific autoimmune diseases such as gastritis, oophoritis, thyroiditis,
or insulitis developed in athymic nu/nu mice after engraftment of the thymus
from euthymic nub + mice treated with cyclosporin A (CsA), a potent immuno-
suppressant. The development of autoimmune disease in the nu/nu mice was
prevented by inoculation of thymocyte suspensions prepared from normal nub
-F mice, but not by thymocyte suspensions from CsA-treated nub+ mice.
Cotransplantation of normal nu/+ mouse thymus with CsA-treated thymus also
suppressed the development of autoimmune disease. Inoculation of spleen cell
Group Treatment of nu/nu mice
Incidence
Gastritis
of autoimmune
nu/nu mice*
Oophoritis
disases in
Thyroiditis
A Transplantation of CsA-treated nu/-I- thymusl 4/5 3/5 0/5
B Transplantation of CsA-treated nu/-I- thymus 0/6 0/6 0/6
plus inoculation of spleen cells from adult
nu/-I- mice$
C Transplantation of CsA-thymus plus 5/5 3/5 0/5
inoculation of spleen cellsfrom newborn
nu/-h micellSAKAGUCHIANDSAKAGUCHI
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suspensions prepared from normal adult nu/ -1- mice prevented autoimmune dis-
ease, but inoculation of those from newborn nu/ -f- mice did not. Thus, CsA
appears to interfere selectively with the thymic production of certain suppressor
T cells controlling self-reactive (autoimmune) T cells, allowing the latter to
expand and cause autoimmune disease.
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